1. Home
  2. CJMB vs UBX Comparison

CJMB vs UBX Comparison

Compare CJMB & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CJMB
  • UBX
  • Stock Information
  • Founded
  • CJMB 2007
  • UBX 2009
  • Country
  • CJMB United States
  • UBX United States
  • Employees
  • CJMB N/A
  • UBX N/A
  • Industry
  • CJMB
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CJMB
  • UBX Health Care
  • Exchange
  • CJMB NYSE
  • UBX Nasdaq
  • Market Cap
  • CJMB 22.0M
  • UBX 20.4M
  • IPO Year
  • CJMB 2025
  • UBX 2018
  • Fundamental
  • Price
  • CJMB $4.41
  • UBX $0.96
  • Analyst Decision
  • CJMB
  • UBX Strong Buy
  • Analyst Count
  • CJMB 0
  • UBX 3
  • Target Price
  • CJMB N/A
  • UBX $5.33
  • AVG Volume (30 Days)
  • CJMB 47.6K
  • UBX 217.7K
  • Earning Date
  • CJMB 01-01-0001
  • UBX 05-13-2025
  • Dividend Yield
  • CJMB N/A
  • UBX N/A
  • EPS Growth
  • CJMB N/A
  • UBX N/A
  • EPS
  • CJMB N/A
  • UBX N/A
  • Revenue
  • CJMB $6,563,412.00
  • UBX N/A
  • Revenue This Year
  • CJMB N/A
  • UBX N/A
  • Revenue Next Year
  • CJMB N/A
  • UBX N/A
  • P/E Ratio
  • CJMB N/A
  • UBX N/A
  • Revenue Growth
  • CJMB N/A
  • UBX N/A
  • 52 Week Low
  • CJMB $3.38
  • UBX $0.94
  • 52 Week High
  • CJMB $7.76
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CJMB N/A
  • UBX 26.07
  • Support Level
  • CJMB N/A
  • UBX $1.16
  • Resistance Level
  • CJMB N/A
  • UBX $1.22
  • Average True Range (ATR)
  • CJMB 0.00
  • UBX 0.13
  • MACD
  • CJMB 0.00
  • UBX -0.07
  • Stochastic Oscillator
  • CJMB 0.00
  • UBX 1.07

About CJMB CALLAN JMB INC

Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics know-how. It provides a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen, in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: